COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Oral Misoprostol Versus Vaginal Dinoprostone For Induction Of Labour: A Randomized Controlled Clinical Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02168881
Recruitment Status : Unknown
Verified June 2014 by Marwan Elkady, Ain Shams University.
Recruitment status was:  Recruiting
First Posted : June 20, 2014
Last Update Posted : June 20, 2014
Information provided by (Responsible Party):
Marwan Elkady, Ain Shams University

Brief Summary:
This study is to compare between oral misoprostol in solution and vaginal dinoprostone in induction of labour in primiparous women with singleton pregnancy as regards efficiency and safety to both mother and fetus.

Condition or disease Intervention/treatment Phase
Labour Induction Drug: Misoprostol Drug: Dinoprostone Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 342 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Study Start Date : May 2014
Estimated Primary Completion Date : January 2016

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Active Comparator: misoprostol
oral misoprostol in solution 25 microgram every 2 hours
Drug: Misoprostol
Active Comparator: dinoprostone
3 mgs dinoprostone vaginally every six hours
Drug: Dinoprostone

Primary Outcome Measures :
  1. induction delivery time [ Time Frame: 2 hourly ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Primigravida
  • >37 wks

Exclusion Criteria:

  • Scarred uterus
  • Macrosomia

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02168881

Layout table for location contacts
Contact: Marwan Osama Elkady +201205533315

Layout table for location information
Ain Shams Maternity hospital Recruiting
Cairo, Egypt
Contact: Ain Shams, hospital         
Sponsors and Collaborators
Ain Shams University
Layout table for additonal information
Responsible Party: Marwan Elkady, Dr, Ain Shams University Identifier: NCT02168881    
Other Study ID Numbers: Misoprostol-2014
First Posted: June 20, 2014    Key Record Dates
Last Update Posted: June 20, 2014
Last Verified: June 2014
Keywords provided by Marwan Elkady, Ain Shams University:
Additional relevant MeSH terms:
Layout table for MeSH terms
Abortifacient Agents, Nonsteroidal
Abortifacient Agents
Reproductive Control Agents
Physiological Effects of Drugs
Anti-Ulcer Agents
Gastrointestinal Agents